DNA methylation and primary immune thrombocytopenia

Seminars in Hematology

Volumn 50, Issue SUPPL.1, 2013, Pages

  Li, Huiyuan ^a   Xuan, Min ^a   Yang, Renchi ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD40 LIGAND; CD5 ANTIGEN; CD70 ANTIGEN; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GAMMA INTERFERON; HISTONE DEACETYLASE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 4; PERFORIN; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DNA METHYLATION; GENE EXPRESSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; X CHROMOSOME INACTIVATION;

AUTOIMMUNE DISEASES; DNA METHYLATION; GENE EXPRESSION; HUMANS; THROMBOCYTOPENIA;

EID: 84877658001     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2013.03.022     Document Type: Article

References (129)

1. Jarvinen P., Kaprio J., Makitalo R., Koskenvuo M., Aho K. Systemic lupus erythematosus and related systemic diseases in a nationwide twin cohort: an increased prevalence of disease in MZ twins and concordance of disease features. J Intern Med 1992, 231:67-72.
2. Kyvik K.O., Green A., Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ 1995, 311:913-917.
3. Aho K., Koskenvuo M., Tuominen J., Kaprio J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 1986, 13:899-902.
4. Mumford C.J., Wood N.W., Kellar-Wood H., Thorpe J.W., Miller D.H., Compston D.A. The British Isles survey of multiple sclerosis in twins. Neurology 1994, 44:11-15.
5. Baccarelli A., Wright R.O., Bollati V., et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009, 179:572-578.
6. Tarantini L., Bonzini M., Apostoli P., et al. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environ Health Perspect 2009, 117:217-222.
7. Niles K.M., Chan D., La Salle S., Oakes C.C., Trasler J.M. Critical period of nonpromoter DNA methylation acquisition during prenatal male germ cell development. PLoS One 2011, 6:e24156.
8. Liang P., Song F., Ghosh S., et al. Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development. BMC Genomics 2011, 12:231.
9. Mohandas T., Sparkes R.S., Shapiro L.J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 1981, 211:393-396.
10. Bartolomei M.S., Tilghman S.M. Genomic imprinting in mammals. Annu Rev Genet 1997, 31:493-525.
11. Branno M. Determination of S-adenosylmethionine and S-adenosylhomocysteine in nuclei isolated from sea urchin embryos during early development. Boll Soc Ital Biol Sper 1980, 56:1769-1771.
12. Riggs A.D. X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet 1975, 14:9-25.
13. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
14. Okano M., Xie S., Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998, 19:219-220.
15. Okano M., Xie S., Li E. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res 1998, 26:2536-2540.
16. Hermann A., Schmitt S., Jeltsch A. The human Dnmt2 has residual DNA-(cytosine-C5) methyltransferase activity. J Biol Chem 2003, 278:31717-31721.
17. Goll M.G., Kirpekar F., Maggert K.A., et al. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 2006, 311:395-398.
18. Deplus R., Brenner C., Burgers W.A., et al. Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res 2002, 30:3831-3838.
19. Chedin F., Lieber M.R., Hsieh C.L. The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a. Proc Natl Acad Sci U S A 2002, 99:16916-16921.
20. Hata K., Okano M., Lei H., Li E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development 2002, 129:1983-1993.
21. Brown S.E., Fraga M.F., Weaver I.C., Berdasco M., Szyf M. Variations in DNA methylation patterns during the cell cycle of HeLa cells. Epigenetics 2007, 2:54-65.
22. Bhattacharya S.K., Ramchandani S., Cervoni N., Szyf M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 1999, 397:579-583.
23. Watt F., Molloy P.L. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev 1988, 2:1136-1143.
24. Drewell R.A., Goddard C.J., Thomas J.O., Surani M.A. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucleic Acids Res 2002, 30:1139-1144.
25. Fujita N., Watanabe S., Ichimura T., et al. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem 2003, 278:24132-24138.
26. Hoal-van Helden E.G., van Helden P.D. Age-related methylation changes in DNA may reflect the proliferative potential of organs. Mutat Res 1989, 219:263-266.
27. Cooney C.A., Dave A.A., Wolff G.L. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002, 132:2393S-2400S.
28. Salvador R.A., Burton R.M. Inhibition of the methylation of nicotinamide by chlorpromazine. Biochem Pharmacol 1965, 14:1185-1196.
29. Richardson B.C., Liebling M.R., Hudson J.L. CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation. Clin Immunol Immunopathol 1990, 55:368-381.
30. Schauenstein K., Rossi K., Csordas A. Differential inhibition of mitogen induced T cell proliferation by 5-azacytidine and cytosine-arabinoside. Biochem Biophys Res Commun 1988, 151:548-553.
31. Quddus J., Johnson K.J., Gavalchin J., et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993, 92:38-53.
32. Lin S.Y., Hsieh S.C., Lin Y.C., et al. A whole genome methylation analysis of systemic lupus erythematosus: hypomethylation of the IL10 and IL1R2 promoters is associated with disease activity. Genes Immun 2012, 13:214-220.
33. Deng C., Kaplan M.J., Yang J., et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001, 44:397-407.
34. Sawalha A.H., Jeffries M., Webb R., et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun 2008, 9:368-378.
35. Marlin S.D., Springer T.A. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987, 51:813-819.
36. Lu Q., Ray D., Gutsch D., Richardson B. Effect of DNA methylation and chromatin structure on ITGAL expression. Blood 2002, 99:4503-4508.
37. Richardson B.C., Strahler J.R., Pivirotto T.S., et al. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 1992, 35:647-662.
38. Kaplan M.J., Deng C., Yang J., Richardson B.C. DNA methylation in the regulation of T cell LFA-1 expression. Immunol Invest 2000, 29:411-425.
39. Lu Q., Kaplan M., Ray D., et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002, 46:1282-1291.
40. Oelke K., Lu Q., Richardson D., et al. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors. Arthritis Rheum 2004, 50:1850-1860.
41. Lu Q., Wu A., Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005, 174:6212-6219.
42. Luo Y., Zhao M., Lu Q. Demethylation of promoter regulatory elements contributes to CD70 overexpression in CD4+ T cells from patients with subacute cutaneous lupus erythematosus. Clin Exp Dermatol 2010, 35:425-430.
43. Yin H., Zhao M., Wu X., et al. Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjogren's syndrome. J Dermatol Sci 2010, 59:198-203.
44. Jiang H., Xiao R., Lian X., et al. Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis. Clin Immunol 2012, 143:39-44.
45. Ma L., Zhou Z., Wang H., et al. Increased expressions of DNA methyltransferases contribute to CD70 promoter hypomethylation and over expression of CD70 in ITP. Mol Immunol 2011, 48:1525-1531.
46. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996, 17:138-146.
47. Yung R.L., Quddus J., Chrisp C.E., Johnson K.J., Richardson B.C. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 1995, 154:3025-3035.
48. Yano S., Ghosh P., Kusaba H., Buchholz M., Longo D.L. Effect of promoter methylation on the regulation of IFN-gamma gene during in vitro differentiation of human peripheral blood T cells into a Th2 population. J Immunol 2003, 171:2510-2516.
49. Katamura K., Fukui T., Kiyomasu T., et al. IL-4 and prostaglandin E2 inhibit hypomethylation of the 5' regulatory region of IFN-gamma gene during differentiation of naive CD4+ T cells. Mol Immunol 1998, 35:39-45.
50. Lee D.U., Agarwal S., Rao A. Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 2002, 16:649-660.
51. Kwon N.H., Kim J.S., Lee J.Y., Oh M.J., Choi D.C. DNA methylation and the expression of IL-4 and IFN-gamma promoter genes in patients with bronchial asthma. J Clin Immunol 2008, 28:139-146.
52. Mi X.B., Zeng F.Q. Hypomethylation of interleukin-4 and -6 promoters in T cells from systemic lupus erythematosus patients. Acta Pharmacol Sin 2008, 29:105-112.
53. Lal G., Zhang N., van der Touw W., Ding Y., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009, 182:259-273.
54. Baron U., Floess S., Wieczorek G., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007, 37:2378-2389.
55. Kim H.P. Leo. Abnormal DNA methylation in CD4+ T cells from people with latent autoimmune diabetes in adults. nard WJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 2007, 204:1543-1551.
56. Li Y., Zhao M., Hou C., et al. Abnormal DNA methylation in CD4+ T cells from people with latent autoimmune diabetes in adults. Diabetes Res Clin Pract 2011, 94:242-248.
57. Podack E.R., Hengartner H., Lichtenheld M.G. A central role of perforin in cytolysis?. Annu Rev Immunol 1991, 9:129-157.
58. Lu Q., Wu A., Ray D., et al. DNA methylation and chromatin structure regulate T cell perforin gene expression. J Immunol 2003, 170:5124-5132.
59. Xiao R., Ding Y., Lu Q.J., et al. Effects of 5-azaC on methylation pattern of the perforin promoter of the perforin gene in normal human T cells. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006, 31:843-847.
60. Kaplan M.J., Lu Q., Wu A., Attwood J., Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004, 172:3652-3661.
61. Luo Y., Zhang X., Zhao M., Lu Q. DNA demethylation of the perforin promoter in CD4(+) T cells from patients with subacute cutaneous lupus erythematosus. J Dermatol Sci 2009, 56:33-36.
62. Armenante F., Merola M., Furia A., Palmieri M. Repression of the IL-6 gene is associated with hypermethylation. Biochem Biophys Res Commun 1999, 258:644-647.
63. Nile C.J., Read R.C., Akil M., Duff G.W., Wilson A.G. Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 2008, 58:2686-2693.
64. Ishida K., Kobayashi T., Ito S., et al. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J Periodontol 2012, 83:917-925.
65. Hodge D.R., Xiao W., Clausen P.A., Heidecker G., Szyf M., Farrar W.L. Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 2001, 276:39508-39511.
66. Bruniquel D., Schwartz R.H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 2003, 4:235-240.
67. Murayama A., Sakura K., Nakama M., et al. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. Embo J 2006, 25:1081-1092.
68. Li Y., Ohms S.J., Shannon F.M., Sun C., Fan J.Y. IL-2 and GM-CSF are regulated by DNA demethylation during activation of T cells, B cells and macrophages. Biochem Biophys Res Commun 2012, 419:748.
69. Hedrich C.M., Rauen T., Tsokos G.C. cAMP-responsive element modulator (CREM)alpha protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus. J Biol Chem 2011, 286:43429-43436.
70. Zhou Y., Yuan J., Pan Y., et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol 2009, 132:362-370.
71. Liao J., Liang G., Xie S., et al. CD40L demethylation in CD4(+) T cells from women with rheumatoid arthritis. Clin Immunol 2012, 145:13-18.
72. Lian X., Xiao R., Hu X., et al. DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum 2012, 64:2338-2345.
73. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
74. Lleo A., Liao J., Invernizzi P., et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 2012, 55:153-160.
75. Renaudineau Y., Hillion S., Saraux A., Mageed R.A., Youinou P. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes. Blood 2005, 106:2781-2789.
76. Youinou P., Renaudineau Y. CD5 expression in B cells from patients with systemic lupus erythematosus. Crit Rev Immunol 2011, 31:31-42.
77. Garaud S., Le Dantec C., Jousse-Joulin S., et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 2009, 182:5623-5632.
78. Garaud S, Le Dantec C, Berthou C, Lydyard PM, Youinou P, Renaudineau Y. Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes. J Immunol. 2008;181:2010-18.
79. Lei W., Luo Y., Lei W., et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009, 38:369-374.
80. Richardson B., Scheinbart L., Strahler J., Gross L., Hanash S., Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990, 33:1665-1673.
81. Tao J., Yang M., Chen Z., et al. Decreased DNA methyltransferase 3A and 3B mRNA expression in peripheral blood mononuclear cells and increased plasma SAH concentration in adult patients with idiopathic thrombocytopenic purpura. J Clin Immunol 2008, 28:432-439.
82. Ogasawara H., Okada M., Kaneko H., Hishikawa T., Sekigawa I., Hashimoto H. Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. Clin Exp Rheumatol 2003, 21:733-738.
83. Zhao M, Tang J, Gao F, et al. Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus. J Biomed Biotechnol: 2010:931018.
84. Xu J., Zhang G., Cheng Y., et al. Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Lupus 2011, 20:678-689.
85. Sunahori K., Juang Y.T., Kyttaris V.C., Tsokos G.C. Promoter hypomethylation results in increased expression of protein phosphatase 2A in T cells from patients with systemic lupus erythematosus. J Immunol 2011, 186:4508-4517.
86. Javierre B.M., Fernandez A.F., Richter J., et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010, 20:170-179.
87. Basu D., Liu Y., Wu A., et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J Immunol 2009, 183:3481-3487.
88. Li Y., Zhao M., Yin H., et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum 2010, 62:1438-1447.
89. Jeffries M.A., Dozmorov M., Tang Y., Merrill J.T., Wren J.D., Sawalha A.H., Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus. Epigenetics 2011, 6:593-601.
90. Liu C.C., Fang T.J., Ou T.T., et al. Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis. Immunol Lett 2011, 135:96-99.
91. Karouzakis E., Rengel Y., Jungel A., et al. DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. Genes Immun 2011, 12:643-652.
92. Fu L.H., Cong B., Zhen Y.F., et al. Methylation status of the IL-10 gene promoter in the peripheral blood mononuclear cells of rheumatoid arthritis patients. Yi Chuan 2007, 29:1357-1361.
93. Takami N., Osawa K., Miura Y., et al. Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum 2006, 54:779-787.
94. Han J., Park S.G., Bae J.B., et al. The characteristics of genome-wide DNA methylation in naive CD4+ T cells of patients with psoriasis or atopic dermatitis. Biochem Biophys Res Commun 2012, 422:157-163.
95. Zhang P., Su Y., Chen H., Zhao M., Lu Q. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J Dermatol Sci 2010, 60:40-42.
96. Zhang K., Zhang R., Li X., Yin G., Niu X. Promoter methylation status of p15 and p21 genes in HPP-CFCs of bone marrow of patients with psoriasis. Eur J Dermatol 2009, 19:141-146.
97. Zhang K., Zhang R., Li X., Yin G., Niu X., Hou R. The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis. Clin Exp Dermatol 2007, 32:702-708.
98. Ruchusatsawat K., Wongpiyabovorn J., Shuangshoti S., Hirankarn N., Mutirangura A. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J Mol Med (Berl) 2006, 84:175-182.
99. Chen M., Chen Z.Q., Cui P.G., et al. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br J Dermatol 2008, 158:987-993.
100. Mastronardi F.G., Noor A., Wood D.D., Paton T., Moscarello M.A. Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated. J Neurosci Res 2007, 85:2006-2016.
101. Kumagai C., Kalman B., Middleton F.A., Vyshkina T., Massa P.T. Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects. J Neuroimmunol 2012, 246:51-57.
102. Calabrese R., Zampieri M., Mechelli R., et al. Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood. Mult Scler 2012, 18:299-304.
103. Hedrich C.M., Rauen T. Epigenetic patterns in systemic sclerosis and their contribution to attenuated CD70 signaling cascades. Clin Immunol 2012, 143:1-3.
104. Fradin D., Le Fur S., Mille C., et al. Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes. PLoS One 2012, 7:e36278.
105. Saito S., Kato J., Hiraoka S., et al. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm Bowel Dis 2011, 17:1955-1965.
106. Tahara T., Shibata T., Nakamura M., et al. Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int J Mol Med 2009, 23:521-527.
107. Hsieh C.J., Klump B., Holzmann K., Borchard F., Gregor M., Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998, 58:3942-3945.
108. Moriyama T., Matsumoto T., Nakamura S., et al. Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis. Dis Colon Rectum 2007, 50:1384-1392.
109. Arasaradnam R.P., Khoo K., Bradburn M., Mathers J.C., Kelly S.B. DNA methylation of ESR-1 and N-33 in colorectal mucosa of patients with ulcerative colitis (UC). Epigenetics 2010, 5:422-426.
110. Tahara T., Shibata T., Nakamura M., et al. Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC). Clin Exp Med 2009, 9:125-130.
111. Wang T., Wang Z., Yang R. Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura. Crit Rev Oncol Hematol 2011, 77:172-183.
112. Panitsas F.P., Theodoropoulou M., Kouraklis A., et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 2004, 103:2645-2647.
113. Semple J.W., Milev Y., Cosgrave D., et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 1996, 87:4245-4254.
114. Olsson B., Andersson P.O., Jernas M., et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 2003, 9:1123-1124.
115. Semple J.W., Provan D., Garvey M.B., Freedman J. Recent progress in understanding the pathogenesis of immune thrombocytopenia. Curr Opin Hematol 2010, 17:590-595.
116. Hauch T.W., Rosse W.F. Platelet-bound complement (C3) in immune thrombocytopenia. Blood 1977, 50:1129-1136.
117. Melnyk S., Pogribna M., Pogribny I.P., Yi P., James S.J. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations. Clin Chem 2000, 46:265-272.
118. De Abreu R., Lambooy L., Stet E., Vogels-Mentink T., Van den Heuvel L. Thiopurine induced disturbance of DNA methylation in human malignant cells. Adv Enzyme Regul 1995, 35:251-263.
119. El-Shiekh E.H., Bessa S.S., Abdou S.M., El-Refaey W.A. Role of DNA methyltransferase 3A mRNA expression in Egyptian patients with idiopathic thrombocytopenic purpura. Int J Lab Hematol 2012, 34:369-376.
120. Hoffman D.R., Cornatzer W.E., Duerre J.A. Relationship between tissue levels of S-adenosylmethionine, S-adenylhomocysteine, and transmethylation reactions. Can J Biochem 1979, 57:56-65.
121. Chen Z.P., Gu D.S., Zhou Z.P., et al. Decreased expression of MBD2 and MBD4 gene and genomic-wide hypomethylation in patients with primary immune thrombocytopenia. Hum Immunol 2011, 72:486-491.
122. Hutchins A.S., Artis D., Hendrich B.D., Bird A.P., Scott P., Reiner S.L. Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunity. J Immunol 2005, 175:5606-5610.
123. Ma L., Zhou Z., Jia H., et al. Effects of CD70 and CD11a in immune thrombocytopenia patients. J Clin Immunol 2011, 31:632-642.
124. Zhao H., Du W., Wang D., et al. The expression of IFN-gamma, IL-4, Foxp3 and perforin genes are not correlated with DNA methylation status in patients with immune thrombocytopenic purpura. Platelets 2012, 21:137-143.
125. Chen Z., Zhou Z., Chen X., et al. Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population. J Clin Immunol 2008, 28:399-404.
126. Shaheen I.A., Abukhalil R.E., Ali D.K., Afifi R.A. DNMT3B promoter polymorphism and risk of immune thrombocytopenic purpura in pediatric Egyptians. Blood Coagul Fibrinolysis 2012, 23:636-639.
127. Zhao H., Du W., Gu D., et al. DNMT3B 579G>T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population. Acta Haematol 2009, 122:31-35.
128. Hendrich B., Hardeland U., Ng H.H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 1999, 401:301-304.
129. Zhao H., Du W., Wang D., et al. Single nucleotide polymorphism in the methyl-CpG binding domain 4 gene and the risk for immune thrombocytopenic purpura in Chinese population. Platelets 2010, 21:132-136.